365 related articles for article (PubMed ID: 29300013)
21. Glucagon-like peptide-1 receptor ligand interactions: structural cross talk between ligands and the extracellular domain.
West GM; Willard FS; Sloop KW; Showalter AD; Pascal BD; Griffin PR
PLoS One; 2014; 9(9):e105683. PubMed ID: 25180755
[TBL] [Abstract][Full Text] [Related]
22. Insights into the structure of class B GPCRs.
Hollenstein K; de Graaf C; Bortolato A; Wang MW; Marshall FH; Stevens RC
Trends Pharmacol Sci; 2014 Jan; 35(1):12-22. PubMed ID: 24359917
[TBL] [Abstract][Full Text] [Related]
23. Full-length human GLP-1 receptor structure without orthosteric ligands.
Wu F; Yang L; Hang K; Laursen M; Wu L; Han GW; Ren Q; Roed NK; Lin G; Hanson MA; Jiang H; Wang MW; Reedtz-Runge S; Song G; Stevens RC
Nat Commun; 2020 Mar; 11(1):1272. PubMed ID: 32152292
[TBL] [Abstract][Full Text] [Related]
24. Structural Mapping and Functional Characterization of Zebrafish Class B G-Protein Coupled Receptor (GPCR) with Dual Ligand Selectivity towards GLP-1 and Glucagon.
Oren DA; Wei Y; Skrabanek L; Chow BK; Mommsen T; Mojsov S
PLoS One; 2016; 11(12):e0167718. PubMed ID: 27930690
[TBL] [Abstract][Full Text] [Related]
25. Extending the Structural View of Class B GPCRs.
de Graaf C; Song G; Cao C; Zhao Q; Wang MW; Wu B; Stevens RC
Trends Biochem Sci; 2017 Dec; 42(12):946-960. PubMed ID: 29132948
[TBL] [Abstract][Full Text] [Related]
26. Structural insight into antibody-mediated antagonism of the Glucagon-like peptide-1 Receptor.
Hennen S; Kodra JT; Soroka V; Krogh BO; Wu X; Kaastrup P; Ørskov C; Rønn SG; Schluckebier G; Barbateskovic S; Gandhi PS; Reedtz-Runge S
Sci Rep; 2016 May; 6():26236. PubMed ID: 27196125
[TBL] [Abstract][Full Text] [Related]
27. Roles of specific extracellular domains of the glucagon receptor in ligand binding and signaling.
Unson CG; Wu CR; Jiang Y; Yoo B; Cheung C; Sakmar TP; Merrifield RB
Biochemistry; 2002 Oct; 41(39):11795-803. PubMed ID: 12269822
[TBL] [Abstract][Full Text] [Related]
28. Mechanochemical Activation of Class-B G-Protein-Coupled Receptor upon Peptide-Ligand Binding.
Lo Giudice C; Zhang H; Wu B; Alsteens D
Nano Lett; 2020 Jul; 20(7):5575-5582. PubMed ID: 32578992
[TBL] [Abstract][Full Text] [Related]
29. Human GLP-1 receptor transmembrane domain structure in complex with allosteric modulators.
Song G; Yang D; Wang Y; de Graaf C; Zhou Q; Jiang S; Liu K; Cai X; Dai A; Lin G; Liu D; Wu F; Wu Y; Zhao S; Ye L; Han GW; Lau J; Wu B; Hanson MA; Liu ZJ; Wang MW; Stevens RC
Nature; 2017 Jun; 546(7657):312-315. PubMed ID: 28514449
[TBL] [Abstract][Full Text] [Related]
30. The Glycosphingolipid GM3 Modulates Conformational Dynamics of the Glucagon Receptor.
Ansell TB; Song W; Sansom MSP
Biophys J; 2020 Jul; 119(2):300-313. PubMed ID: 32610088
[TBL] [Abstract][Full Text] [Related]
31. Two distinct domains of the glucagon-like peptide-1 receptor control peptide-mediated biased agonism.
Lei S; Clydesdale L; Dai A; Cai X; Feng Y; Yang D; Liang YL; Koole C; Zhao P; Coudrat T; Christopoulos A; Wang MW; Wootten D; Sexton PM
J Biol Chem; 2018 Jun; 293(24):9370-9387. PubMed ID: 29717000
[TBL] [Abstract][Full Text] [Related]
32. Peptide recognition, signaling and modulation of class B G protein-coupled receptors.
Cao C; Zhang H; Yang Z; Wu B
Curr Opin Struct Biol; 2018 Aug; 51():53-60. PubMed ID: 29567494
[TBL] [Abstract][Full Text] [Related]
33. Predicted structure of agonist-bound glucagon-like peptide 1 receptor, a class B G protein-coupled receptor.
Kirkpatrick A; Heo J; Abrol R; Goddard WA
Proc Natl Acad Sci U S A; 2012 Dec; 109(49):19988-93. PubMed ID: 23169631
[TBL] [Abstract][Full Text] [Related]
34. Identification of key residues for the binding of glucagon to the N-terminal domain of its receptor: an alanine scan and modeling study.
Prévost M; Vertongen P; Waelbroeck M
Horm Metab Res; 2012 Oct; 44(11):804-9. PubMed ID: 22893257
[TBL] [Abstract][Full Text] [Related]
35. Conformational and molecular interaction studies of glucagon-like peptide-2 with its N-terminal extracellular receptor domain.
Venneti KC; Hewage CM
FEBS Lett; 2011 Jan; 585(2):346-52. PubMed ID: 21167157
[TBL] [Abstract][Full Text] [Related]
36. Different domains of the glucagon and glucagon-like peptide-1 receptors provide the critical determinants of ligand selectivity.
Runge S; Wulff BS; Madsen K; Bräuner-Osborne H; Knudsen LB
Br J Pharmacol; 2003 Mar; 138(5):787-94. PubMed ID: 12642379
[TBL] [Abstract][Full Text] [Related]
37. Structural basis of G
Qiao A; Han S; Li X; Li Z; Zhao P; Dai A; Chang R; Tai L; Tan Q; Chu X; Ma L; Thorsen TS; Reedtz-Runge S; Yang D; Wang MW; Sexton PM; Wootten D; Sun F; Zhao Q; Wu B
Science; 2020 Mar; 367(6484):1346-1352. PubMed ID: 32193322
[TBL] [Abstract][Full Text] [Related]
38. Molecular determinants of glucagon receptor signaling.
Unson CG
Biopolymers; 2002; 66(4):218-35. PubMed ID: 12491536
[TBL] [Abstract][Full Text] [Related]
39. A model for receptor-peptide binding at the glucagon-like peptide-1 (GLP-1) receptor through the analysis of truncated ligands and receptors.
Al-Sabah S; Donnelly D
Br J Pharmacol; 2003 Sep; 140(2):339-46. PubMed ID: 12970080
[TBL] [Abstract][Full Text] [Related]
40. Inhibitory mechanism of an allosteric antibody targeting the glucagon receptor.
Mukund S; Shang Y; Clarke HJ; Madjidi A; Corn JE; Kates L; Kolumam G; Chiang V; Luis E; Murray J; Zhang Y; Hötzel I; Koth CM; Allan BB
J Biol Chem; 2013 Dec; 288(50):36168-78. PubMed ID: 24189067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
